OQS
HIMS icon

Occudo Quantitative Strategies’s Hims & Hers Health HIMS Stock Holding History

Occudo Quantitative Strategies’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
144,404
+112,956
+359% +$3.03M 0.27% 110
2026
Q1 		$854K Buy
+31,448
New +$743K 0.05% 419
2024
Q3 		– Sell
-15,924
Closed -$322K – 837
2024
Q2 		$322K Sell
15,924
-43,754
-73% -$728K 0.06% 434
2024
Q1 		$923K Buy
+59,678
New +$673K 0.16% 179
2023
Q4 		– Sell
-173,200
Closed -$1.09M – 953
2023
Q3 		$1.09M Sell
173,200
-64,432
-27% -$479K 0.14% 228
2023
Q2 		$2.23M Sell
237,632
-24,319
-9% -$241K 0.23% 120
2023
Q1 		$2.6M Buy
261,951
+9,287
+4% +$81.4K 0.24% 122
2022
Q4 		$1.62M Buy
252,664
+47,860
+23% +$272K 0.19% 162
2022
Q3 		$1.14M Sell
204,804
-27,561
-12% -$166K 0.09% 356
2022
Q2 		$1.05M Sell
232,365
-35,901
-13% -$153K 0.09% 367
2022
Q1 		$1.43M Sell
268,266
-41,701
-13% -$206K 0.12% 269
2021
Q4 		$2.03M Buy
+309,967
New +$2.24M 0.18% 152

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Occudo Quantitative Strategies's HIMS Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Hims & Hers Health (HIMS) stake by 359% in Q2 2026, buying an estimated $3.03M and bringing the position to 144,404 shares worth $5.01M. The position accounts for 0.27% of the portfolio, ranked #110.

Occudo Quantitative Strategies first reported a position in HIMS in Q4 2021 and has held it in 12 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Occudo Quantitative Strategies held 144,404 shares of Hims & Hers Health worth $5.01M as of Q2 2026.
  • Occudo Quantitative Strategies bought 112,956 Hims & Hers Health shares in Q2 2026, an estimated $3.03M.
  • Hims & Hers Health made up 0.27% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #110 holding.
  • Occudo Quantitative Strategies first reported a position in Hims & Hers Health in Q4 2021 and has held it in 12 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.